Agennix Incorporated

AGENNIX

pharmaceutical compositions, vitamins and food additives;

AGENNIX

pharmaceutical preparations used to treat infectious diseases and stimulate the immune system;

AGENNIX

Pharmaceutical preparations used to treat cancer, sepsis, infections and wounds, and to modulate the immune system;

DCA

Pharmaceutical preparations for the treatment of elevated circulating cholesterol, vascular inflammation, atherosclerosis, cardiovascular disease, diabetes mellitus, infection and/or inflammation in immunosuppressed subjects, cancer, organ transplant rejection and graft-versus-host-disease, bacteremia, sepsis, septic shock, Acute Respiratory Distress Syndrome, pain, wounds, respiratory disorders, neurofibromatosis, rheumatoid arthritis, Waginer's granulomatosis, Kawasaki's disease, lupus erathematosis, midline granuloma, inflammatory bowel disease, osteoarthritis, leiomyomas, adenomas, lipomas, hemangiomas, fibromas, vascular occlusion, restenosis, pre-neoplastic lesions, carcinoma in situ, oral hairy leukoplakia, psoriasis, pre-leukemias, anemia with excess blasts, and myelodysplastic syndrome;